NeueHealth Inc (NEUE) AI Stock Analysis

• Market Cap: $61.16M
• Dividend Yield: N/A
• Average Volume (3M): 6.54K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.27
• Revenue Growth: -17.91%
• EPS Growth: 83.17%
• Country: US
• Employees: 986
• Sector: Healthcare
• Sector Strength: 48
• Industry: Medical - Equipment & Services
• EPS (TTM): -1.80
• Shares Outstanding: 8,927,758
• 10 Day Avg. Volume: 6,949
• 30 Day Avg. Volume: 6,540
• PEG Ratio: 0.01
• Price to Book (P/B): 0.57
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 1.98
• Enterprise Value/Market Cap: 8.11
• Enterprise Value/Revenue: 0.13
• Enterprise Value/Gross Profit: 2.47
• Enterprise Value/Ebitda: -0.64
• 1Y Price Target: $7.00
• Price Target Upside: 2.64% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 0

• Rating: 51 Neutral
• Price Target: $7.00 ▲(2.64%Upside)

NeueHealth Inc.'s overall stock score reflects significant financial struggles with ongoing losses and liquidity concerns, offset by positive technical indicators and a strong earnings call that highlighted consumer growth and strategic initiatives. The valuation remains weak due to negative earnings. The combination results in a moderate score, indicating mixed prospects.

NeueHealth Inc Business Overview & Revenue Model

Company Description

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.

How the Company Makes Money

NeueHealth Inc generates revenue through a combination of subscription fees for its telemedicine platform, licensing fees for its healthcare data analytics tools, and service fees for personalized health management solutions. The company collaborates with healthcare providers and insurance companies to facilitate the integration of its solutions into existing healthcare systems, which enhances its market reach and revenue potential. Additionally, NeueHealth forms strategic partnerships with technology companies to co-develop and deploy cutting-edge digital health solutions, further contributing to its earnings.

NeueHealth Inc Financial Statement Overview

Summary

NeueHealth Inc. is facing substantial financial challenges, with negative profit margins and significant operational losses. The company's balance sheet shows financial instability with negative stockholders' equity, and cash flow issues are evident with negative operating and free cash flows.

Income Statement

NeueHealth Inc. has experienced volatility in its revenue stream, with a recent decline from the previous year. Despite generating substantial total revenue of $907.3M in TTM, the company suffers from negative profit margins, with a significant net loss of $143.6M due to high operating expenses. Continued negative EBIT and EBITDA margins further reflect operational challenges.

Balance Sheet

The balance sheet of NeueHealth Inc. reveals financial instability. The company has negative stockholders' equity of $1.36B, indicating liabilities exceed assets. With a low total debt of $1M, the debt-to-equity ratio calculation is not meaningful. The negative equity ratio and significant liabilities pose a risk to financial solvency.

Cash Flow

Cash flow analysis shows negative operating cash flow of $95.5M in TTM, highlighting ongoing cash management issues. The free cash flow remains negative, further stressing the company's liquidity position. The negative cash flow to net income ratios indicate difficulties in converting earnings to available cash.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
907.35M	936.66M	1.16B	751.16M	1.51B	514.89M
	Gross Profit
201.19M	194.52M	164.22M	88.19M	218.88M	62.97M
	EBIT
-81.65M	-102.06M	-577.00M	-368.76M	-343.63M	-170.38M
	EBITDA
-97.13M	-80.76M	-566.80M	-246.39M	-308.58M	-249.31M
	Net Income Common Stockholders
-143.64M	-134.68M	-1.15B	-1.46B	-1.18B	-248.44M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
145.10M	93.17M	93.56M	217.88M	433.76M	988.30M
	Total Assets
895.68M	544.38M	1.23B	4.67B	3.60B	1.81B
	Total Debt
1.00M	204.61M	370.35M	303.95M	155.00M	28.42M
	Net Debt
-137.10M	121.32M	283.05M	86.94M	-134.28M	-459.95M
	Total Liabilities
1.29B	930.49M	1.48B	3.73B	2.32B	2.27B
	Stockholders Equity
-1.36B	-434.69M	-343.53M	719.93M	1.15B	-503.67M
Cash Flow		Free Cash Flow
-98.84M	-125.55M	-2.73B	207.02M	51.65M	-63.71M
	Operating Cash Flow
-95.55M	-123.22M	-2.73B	234.47M	82.06M	-57.24M
	Investing Cash Flow
53.57M	186.89M	1.12B	-429.72M	-552.89M	-689.74M
	Financing Cash Flow
17.38M	-253.55M	49.91M	1.07B	1.04B	712.44M

NeueHealth Inc Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 6.82
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NEUE, the sentiment is Positive. The current price of 6.82 is above the 20-day moving average (MA) of 6.81, above the 50-day MA of 6.73, and above the 200-day MA of 6.18, indicating a bullish trend. The MACD of 0.02 indicates Positive momentum. The RSI at 54.51 is Neutral, neither overbought nor oversold. The STOCH value of 79.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NEUE.

NeueHealth Inc Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CON	73 Outperform	$2.68B	16.95	20.83%	1.20%	―	―
CCLD	68 Neutral	$106.65M	―	21.00%	―	-0.45%	94.32%
Sector *	53 Neutral	$5.24B	3.32	-44.36%	6.63%	16.78%	-0.12%
NEUE	51 Neutral	$61.16M	―	84.03%	―	-17.91%	83.17%
HYPR	51 Neutral	$54.43M	―	-67.86%	―	0.34%	6.20%
AVTX	47 Neutral	$51.54M	―	678.24%	―	-69.59%	―
CBUS	40 Underperform	$73.65M	―	-157.73%	―	104.78%	40.41%

NeueHealth Inc Corporate Events

NeueHealth Inc Holds Annual Stockholders Meeting

On May 29, 2025, NeueHealth, Inc. held its annual meeting of stockholders where several key decisions were made. The stockholders elected ten directors to serve until the 2026 annual meeting, ratified the appointment of Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and approved the executive compensation for 2024 on a non-binding, advisory basis.

The most recent analyst rating on (NEUE) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on NeueHealth Inc stock, see the NEUE Stock Forecast page.

NeueHealth Inc Approves Merger with NH Holdings

On May 7, 2025, NeueHealth, Inc. held a special meeting of stockholders to consider proposals related to a merger agreement with NH Holdings 2025, Inc. and its subsidiary. The merger will result in NeueHealth becoming a wholly owned subsidiary and no longer a public company. The proposals, including the merger agreement, adjournment, and merger-related compensation, were approved by the stockholders, indicating a significant shift in the company’s structure and ownership.